Lithium's antiviral effects: a potential drug for CoViD-19 disease?

Andrea MurruMirko ManchiaTomas HajekRené E NielsenJanusz K RybakowskiGabriele SaniThomas G SchulzeLeonardo TondoMichael Bauernull null

Published in: International journal of bipolar disorders (2020)

Lithium presents a clear antiviral activity demonstrated at preclinical level, but that remains to be confirmed in clinical settings. In addition, the pleiotropic mechanisms of action of lithium may provide an insight for its possible use as antiviral agent targeting specific pathways.

Keyphrases

solid state
coronavirus disease
sars cov
cancer therapy
emergency department
cell therapy
risk assessment
drug delivery
human health
mesenchymal stem cells
bone marrow
adverse drug
respiratory syndrome coronavirus
drug induced
climate change